Announced details
Healthcare and public services
Achieved monthly operating profitability in February and March 2026, marking the first consecutive monthly profitability
An indirect subsidiary of the Company. POCKETALK Corporation is a consolidated subsidiary.
POCKETALK B.V.: headquartered in the Netherlands and led by CEO Joe Miller. An indirect subsidiary of the Company that operates the POCKETALK business in Europe.
DTAC / DCB0129 (assessments for healthcare institutions in the United Kingdom)
Netherlands
The European business is at a stage where the foundations for sustainable operations are gradually being established
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | POCKETALK series |
| Counterparty overview | POCKETALK B.V.: headquartered in the Netherlands and led by CEO Joe Miller. An indirect subsidiary of the Company that operates the POCKETALK business in Europe. |
| Relationship with the Company | An indirect subsidiary of the Company. POCKETALK Corporation is a consolidated subsidiary. |
| Applicable area | Healthcare and public services |
| Award/certification name | DTAC / DCB0129 (assessments for healthcare institutions in the United Kingdom) |
| Location | Netherlands |
| Quantitative Effects | Achieved monthly operating profitability in February and March 2026, marking the first consecutive monthly profitability |
| Impact on Business Performance | The European business is at a stage where the foundations for sustainable operations are gradually being established |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Expansion of the distributor network on the sales side, more efficient business operations through a review of staffing and promotional expenses, and increased opportunities for adoption in the healthcare sector following completion of the DTAC / DCB0129 assessments for healthcare institutions in the United Kingdom.